Claude Capron
Overview
Explore the profile of Claude Capron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1014
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akli A, Takam Kamga P, Julie C, Capron C, Costantini A, Dumenil C, et al.
Cancer Immunol Immunother
. 2025 Jan;
74(2):58.
PMID: 39751636
Most of advanced non-small cell lung cancer (NSCLC) patients will experience tumor progression with immunotherapy (IO). Preliminary data suggested an association between high plasma HGF levels and poor response to...
2.
Bentaleb C, Adrouche S, Finkelstein J, Devisme C, Callens N, Capron C, et al.
J Mol Cell Biol
. 2024 Oct;
PMID: 39354676
Despite an undetectable plasma viral load as a result of antiretroviral therapy, HIV-1-infected individuals with poor immune reconstitution harbor infectious HIV-1 within their platelets. Megakaryocytes, as platelet precursors, are the...
3.
Zhu J, Bouzid R, Travert B, Geri G, Cohen Y, Picod A, et al.
Front Med (Lausanne)
. 2024 Jun;
11:1399335.
PMID: 38915768
Background: The COVID-19 pandemic related to SARS-CoV-2 virus was responsible for global pandemic. The severe form of the disease was linked to excessive activation of immune pathways together with a...
4.
Seguin J, El Hajjam M, Legagneux J, Diakhaby S, Mignet N, Boudy V, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543209
Radiofrequency ablation (RFA) of cancer induces an anti-tumor immunity, which is insufficient to prevent recurrences. In mice, RFA-intratumoral immunotherapy by granulocyte-macrophage colony-stimulating factor (GM-CSF) and Bacillus Calmette-Guerin resulted in complete...
5.
Grindel A, Fretellier N, Soares M, Bouzakher N, Millot Maysounabe V, Santus R, et al.
Front Immunol
. 2024 Jan;
14:1272246.
PMID: 38292484
Introduction: Local treatments of cancer, including transarterial chemoembolization, could enhance responses to systemic immune checkpoint inhibitors such as anti-PD-1 antibodies. Lipiodol, a radiopaque oil, is widely used for transarterial chemoembolization...
6.
Takam Kamga P, Mayenga M, Sebane L, Costantini A, Julie C, Capron C, et al.
Lung Cancer
. 2024 Jan;
188:107447.
PMID: 38176297
The identification of biomarkers related to treatment in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) represents a significant challenge. The aim of this study...
7.
Assinger A, Capron C, Real F, Bomsel M
Front Immunol
. 2023 Apr;
14():1175200.
PMID: 37056755
No abstract available.
8.
Ruiz M, Siracusano G, Cottignies-Calamarte A, Tudor D, Real F, Zhu A, et al.
Front Immunol
. 2022 Oct;
13:842468.
PMID: 36248831
Highlights: Mucosal pulmonary antibody response in COVID-19 outcome remains unclear. We show that in severe COVID-19 patients, mucosal pulmonary non-neutralizing SARS-CoV-2 IgA persit after viral clearance in the lung. Furthermore,...
9.
Zhu A, Real F, Capron C, Rosenberg A, Silvin A, Dunsmore G, et al.
Cell Mol Life Sci
. 2022 Jun;
79(7):365.
PMID: 35708858
SARS-CoV-2, although not being a circulatory virus, spread from the respiratory tract resulting in multiorgan failures and thrombotic complications, the hallmarks of fatal COVID-19. A convergent contributor could be platelets...
10.
Randrian V, Pernot S, Le Malicot K, Catena V, Baumgaertner I, Tacher V, et al.
Dig Liver Dis
. 2022 May;
54(7):857-863.
PMID: 35610167
Immune checkpoint inhibitors (ICI) have high efficacy in metastatic colorectal cancer (mCRC) with microsatellite instability (MSI) but not in microsatellite stable (MSS) tumour due to the low tumour mutational burden....